KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 101 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 1.43 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,923,000 | -7.0% | 565,578 | +2.9% | 0.00% | -50.0% |
| Q2 2018 | $2,067,000 | -5.9% | 549,724 | +2.4% | 0.00% | 0.0% |
| Q1 2018 | $2,197,000 | -9.0% | 536,951 | +3.4% | 0.00% | 0.0% |
| Q4 2017 | $2,415,000 | -31.4% | 519,331 | +4.7% | 0.00% | -33.3% |
| Q3 2017 | $3,521,000 | +10.4% | 495,896 | +12.4% | 0.00% | 0.0% |
| Q2 2017 | $3,190,000 | +18.5% | 441,106 | +1.0% | 0.00% | 0.0% |
| Q1 2017 | $2,691,000 | +11.8% | 436,718 | +6.3% | 0.00% | 0.0% |
| Q4 2016 | $2,408,000 | +17.2% | 410,876 | +6.2% | 0.00% | +50.0% |
| Q3 2016 | $2,054,000 | -15.4% | 386,743 | +5.5% | 0.00% | -33.3% |
| Q2 2016 | $2,427,000 | +35.0% | 366,551 | -4.7% | 0.00% | +50.0% |
| Q1 2016 | $1,798,000 | -5.3% | 384,827 | +2.4% | 0.00% | -33.3% |
| Q4 2015 | $1,898,000 | +48.7% | 375,655 | +3.7% | 0.00% | +50.0% |
| Q3 2015 | $1,276,000 | -58.9% | 362,250 | +16.6% | 0.00% | -50.0% |
| Q2 2015 | $3,101,000 | -19.1% | 310,683 | +3.2% | 0.00% | -20.0% |
| Q1 2015 | $3,834,000 | +4.2% | 301,153 | +15.9% | 0.01% | -16.7% |
| Q4 2014 | $3,679,000 | +6.1% | 259,948 | +3.1% | 0.01% | 0.0% |
| Q3 2014 | $3,467,000 | -1.8% | 252,137 | +9.8% | 0.01% | 0.0% |
| Q2 2014 | $3,532,000 | -10.2% | 229,598 | -0.5% | 0.01% | -14.3% |
| Q1 2014 | $3,932,000 | +60.4% | 230,714 | +21.9% | 0.01% | +40.0% |
| Q4 2013 | $2,452,000 | +35.6% | 189,310 | +8.7% | 0.01% | +25.0% |
| Q3 2013 | $1,808,000 | +35.9% | 174,086 | +3.1% | 0.00% | +33.3% |
| Q2 2013 | $1,330,000 | – | 168,918 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |